Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell death

Breast Cancer Research and Treatment

Volumn 72, Issue 3, 2002, Pages 265-278

  Zhang, Yicheng ^a   Crump, Michael ^b   Berger, Stuart A ^a,c  

^a Arthritis and Immune Disorder Research Centre   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Ca2+; High dose chemotherapy; Multi drug resistance; Purging

Indexed keywords

BOMBESIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; CYTOKERATIN; ECONAZOLE; EPIDERMAL GROWTH FACTOR; KETOTIFEN;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CALCIUM TRANSPORT; CANCER CELL; CANCER CHEMOTHERAPY; CELL DEATH; CELL STIMULATION; CELL STRUCTURE; CELL VIABILITY; CLONOGENESIS; COLONY FORMATION; CONTAMINATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SENSITIVITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STEM CELL MOBILIZATION; BONE MARROW PURGING; BREAST TUMOR; CELL CULTURE; CLONOGENIC ASSAY; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION;

BONE MARROW PURGING; BREAST NEOPLASMS; CELL DEATH; COLONY-FORMING UNITS ASSAY; ECONAZOLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; KETOTIFEN; TUMOR CELLS, CULTURED;

EID: 0036010918     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014965726663     Document Type: Article

References (36)

1. A large, prospective, randomized trial of high-dose combination alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM)
2. Intensive chemotherapy and autograft of hematopoietic stem cells in the treatment of metastatic cancer: Results of the national protocol Pegase 04
3. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
4. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer
5. The status of high-dose chemotherapy in breast cancer
6. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques
7. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction
8. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors
9. Minimal residual disease in autologous hematopoietic harvests from breast cancer patients
10. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
11. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells
12. High-dose therapy for follicular lymphoma
13. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: A phase I trial
14. Elimination of malignant clonogenic breast cancer cells from human bone marrow
15. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: Effect of ex vivo purging with 4-hydroperoxycyclophosphamide
16. Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells
17. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment
18. High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: A randomized multicentre study
19. Peripheral blood progenitor cell mobilization: A clinical review
20. Protection from apoptosis by steel factor but not interleukin- 3 is reversed through blockade of calcium influx
21. The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients
22. Amplification and overexpression of the erbB-2 gene in human tumors: Its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy
23. Basic fibroblast growth factor (bFGF): Mitogenic activity and binding sites in human breast cancer
24. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
25. Production of acidic and basic fibroblast growth factor by the hormone-independent breast cancer cell line MDA-MB-231
26. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
27. 2+ stores in induction and suppression of apoptosis in S 49 cells
28. Capacitative calcium entry channels
29. Effects of hormones and growth factors on the growth of six human breast cancer cell lines in defined media
30. Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: Correlation with the level of occupied EGF receptor
31. Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status
32. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC- 3095 of growth of human breast cancer cell lines
33. Biochemistry of multi-drug resistance mediated by the multi-drug transporter
34. Clinical multi-drug resistance in cancer: A multi-factorial problem
35. On the mechanism of action of econazole, the capacitative calcium inflow blocker